// App-Quantinova.ai

e21650 : Predictive impact of quality of life measurements in chemotherapy treated advanced pancreatic cancer patients at a single Canadian cancer institution.

Researchers

Presenter

  • Christina Kim

Principal Investigators

  • Quincy S. Chu

  • Konrad Fassbender

  • Sunita Ghosh

  • Jennifer L. Spratlin

Medical Centers

  • Cancer Care Manitoba, Winnipeg, MB, Canada

  • Cross Cancer Institute, Edmonton, AB, Canada

  • University of Alberta, Edmonton, AB, Canada

  • Division of Experimental Oncology, Cross Cancer Institute, Edmonton, AB, Canada

  • Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Tuberculosis

  • Solid malignancies

Biomarkers

  • Adenomatous Polyposis Coli

Drug/Treatment

  • Epimorph

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved